Advertisement

Read Now: News and Research From ICAAC 2014
The Body PRO covers the 48th Annual ICAAC/IDSA 46th Annual Meeting; Washington, D.C.; October 25-28, 2008



  

Top Stories

Mari Kitahata, M.D., and Daniel Kuritzkes, M.D. Starting HAART: Should 500 Become the New 350?
Mari Kitahata, M.D., and Daniel Kuritzkes, M.D., discuss a 5,926-patient trial that found a 74% higher mortality risk among those who deferred HAART until their CD4 dropped below 350 rather than initiating when their CD4 was between 351 and 500. Dr. Kuritzkes also touches on new developments in HIV drug resistance.
Read or listen (35 min.):
More Top Stories:

Clinical ManagementComplications & Coinfections

96-Week ARTEMIS Data Indicate Darunavir Is Superior to Lopinavir in Naive Patients

Tony Mills, M.D.Tony Mills, M.D., discusses darunavir's non-inferiority to lopinavir, in 96-week data appear likely to solidify the drug's role in first-line therapy.

Read or listen (4 min.):

More Highlights:

Continuous HAART Associated With Decreased Bone Mineral Density, SMART Substudy Finds

Birgit Grund, Ph.D.In one of ICAAC/IDSA 2008's most talked-about studies, a SMART substudy suggests that participants who remained on HAART continuously experienced a significantly greater reduction in bone marrow density than patients on intermittent therapy. (An interview with Birgit Grund, Ph.D.)

Read or listen (7 min.):

More Highlights:


About This Conference

The Body PRO's coverage of the 48th Annual ICAAC®/IDSA 46th Annual Meeting (ICAAC®/IDSA 2008) will include a wide array of individual presentations and symposia, as well as summaries of some of the hottest topics in HIV research.*

For more information on ICAAC®/IDSA 2008, please visit the conference's Web site. You may also view the conference program planner online.

*ICAAC® is a registered trademark of the American Society for Microbiology Corporation. Neither Body Health Resources Corporation nor its corporate parent, The HealthCentral Network, Inc. is affiliated with the ICAAC Conference or the American Society for Microbiology Corporation.


This coverage was provided by The Body PRO. Copyright © Body Health Resources Corporation. All rights reserved.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

  

ICAAC® is a registered trademark of the American Society for Microbiology Corporation. Neither Body Health Resources Corporation nor its corporate parent, The HealthCentral Network, Inc. is affiliated with the ICAAC Conference or the American Society for Microbiology Corporation.




Latest Additions

Advertisement